Stereotaxis
    Print Page  Close Window
S-1/A
STEREOTAXIS, INC. filed this Form S-1/A on 06/17/2004
Entire Document
 << Previous Page | Next Page >>
Table of Contents

THE OFFERING

 
Common stock offered                                 shares
 
Common stock to be outstanding after the offering                                 shares
 
Use of proceeds For working capital; continued sales, marketing and clinical support initiatives; continued research and development; and general corporate purposes. In addition, we may use a portion of the net proceeds from this offering to repay outstanding lines of credit. See “Use of Proceeds”.
 
Proposed Nasdaq National Market Symbol “STXS”

       The number of shares of our common stock referred to above that will be outstanding immediately after completion of this offering is based on 5,547,175 shares of our common stock outstanding as of March 31, 2004 and also reflects the automatic conversion of our preferred stock into 66,436,116 shares of common stock and the automatic conversion of a convertible promissory note into                               shares of common stock, assuming an offering price of $          per share. This number does not include, as of March 31, 2004:

  •  7,418,310 shares of common stock issuable upon exercise of outstanding options, at a weighted average exercise price of $1.33 per share;
 
  •  4,295,395 shares of common stock issuable upon the exercise of outstanding warrants, at a weighted average exercise price of $2.36 per share; and
 
  •  up to 1,693,257 additional shares of our common stock reserved for issuance under our 2002 Stock Incentive Plan and our 2002 Non-Employee Directors’ Stock Plan. This number does not include additional shares that will be reserved in connection with automatic annual increases to the number of shares issuable under the terms of our 2002 Stock Incentive Plan, as described under “Management — Employee Benefit Plans — 2002 Stock Incentive Plan”.

       Subject to the completion of this offering, we have reserved an additional 1,000,000 shares of common stock for issuance under our 2004 Employee Stock Purchase Plan. In addition, we have agreed to issue an additional                               shares if the underwriters exercise their over-allotment option in full, which we describe in “Underwriting”. If the underwriters exercise this option in full,  shares of common stock will be outstanding after this offering.


       Unless we indicate otherwise, all information in this prospectus:

  •  reflects a                -for-                reverse stock split which we intend to effect prior to the offering;
 
  •  gives effect to the conversion of all outstanding shares of our preferred stock into 66,436,116 shares of our common stock upon the completion of this offering;
 
  •  does not reflect any conversion of outstanding common stock warrants into shares of our common stock pursuant to a deemed cashless exercise, which is described under “Description of Capital Stock — Warrants”;
 
  •  gives effect to the conversion of the outstanding principal and accrued interest under a $2 million cumulative convertible pay-in-kind 8% note issued to Siemens in August 2003 into                               shares of our common stock upon the completion of this offering, assuming an offering price of $          per share; and
 
  •  assumes that the underwriters do not exercise their over-allotment option to purchase additional shares in the offering.

4


 << Previous Page | Next Page >>